Match tier
Institution-verified
Presence
Current · Arkansas
Last published
2026
Sources
Institutional record
Refreshed
2026-10-05
M
Milan Bimali
Sourced from institutional research profiles (UAMS TRI or ARA).
Associate Professor
Also affiliated: Texas Tech University (2025); Arkansas Children's Hospital (2020–2021); University of Kansas (2016–2018); University of Arkansas Medical Center (2021); Yale University (2015–2017); Inari Agriculture (United States) (2022); University of Kansas Medical Center (2014–2015); Arkansas Children's Nutrition Center (2020–2021); Nexus Institute of Research and Innovation (NIRI) (2022–2026); The University of Texas Medical Branch at Galveston (2022); Texas Tech University Health Sciences Center (2025)
10 h-index
69 pubs
418 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Milan Bimali, a biostatistician with experience since 2016, collaborates with investigators at academic health centers. His work involves protocol and grant development, study design, data analysis, and the dissemination of research findings. Bimali leads a research group and has co-authored publications with collaborators including Tremaine B. Williams, Pearman D. Parker, Emel Seker, and Taren Swindle, all from the University of Arkansas for Medical Sciences.
His publication record spans various medical and health-related topics. Recent work includes investigations into the associations between perfusate biomarkers and kidney transplant outcomes, the consumption of specific vitamins and their relation to emphysema risk, and methodological challenges in refugee women's health research. Bimali has also contributed to studies on the effectiveness of specific cancer treatments, such as Brentuximab vedotin for Hodgkin lymphoma, and the use of adjuvant chemotherapy in colon cancer patients. His research also extends to technical aspects of medical treatments, including cleaning dose falloff in lung stereotactic body radiation therapy (SBRT) plans.
Bimali's scholarly output is reflected in an h-index of 10, with over 71 total publications and 415 citations. He remains active in research, with his most recent publication in 2026.
Metrics
- h-index: 10
- Publications: 69
- Citations: 418
Positions
-
Associate Professor 2023–presentUniversity of Arkansas for Medical Sciences Biostatistics Institutional directory
Selected Publications
-
Feasibility and Acceptability of an Occupation‑Based Telehealth Intervention for Cancer Survivors: A Pilot Randomized Controlled Trial (2026)The Open Repository - Binghamton (Binghamton University) OpenAlex
-
Prenatal Polyphenol Intake Associates With Cognitive Outcomes in School-Age Children (2026)
-
Audiometric changes during teprotumumab therapy for thyroid eye disease: a prospective pilot study (2026)
-
A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence (2026)
-
(6S)-5-Methyltetrahydrofolate Dicholine Salt Modulates Methyl-Donor Metabolites and Repetitive-Element DNA Methylation in HepaRG Cells (2026)
-
Test-retest reliability and internal consistency of the Occupational Resilience Measure (ORM 1.0) (2026)
-
Test-retest reliability and internal consistency of the Occupational Resilience Measure (ORM 1.0) (2026)The Open Repository - Binghamton (Binghamton University) OpenAlex
-
Falls Risk Associated With Referral Diagnosis for Older Adults Receiving Outpatient Physical Therapy Services (2026)
-
Ethnic disparities in cancer prevalence in Nepal from a 6 year analyses of a single tertiary hospital cancer registry (2026)
-
An instrument for measuring the influence of nursing care on the length of stay in heart failure hospitalizations of African Americans (2026)
-
Social determinants of health and hospitalization risk in heart failure: A Retrospective analysis (2026)
-
Soy Protein-Based Infant Formula Feeding Association with Adolescent Growth, Body Composition, Cardiometabolic Health, and Pubertal Development in Comparison with Cow's Milk-Based Infant Formula and Human Milk Feeding (2026)
-
A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence (2026)
-
Occupational Resilience (Part 2): Toward a Cross-culturally Relevant Measure of a Novel Construct. (2025)PubMed OpenAlex
-
Occupational Resilience (Part 2): Toward a Cross-culturally Relevant Measure of a Novel Construct (2025)
Grants & Funding
As listed on this researcher's institutional profile.
- Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses NIH/NCI
- Leveraging Implementation Science to Increase Access to Trauma Treatment for Incarcerated Drug Users NIH/NIDA
- Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network NIH
Collaboration Network
Top Collaborators
Tremaine B. Williams
University of Arkansas for Medical Sciences
5 shared publications
In database
- Social determinants of health and hospitalization risk in heart failure: A Retrospective analysis
- Registered nurse effect on long length of stay in the heart failure hospitalizations of African Americans
- Sociotechnical Needs of Registered Nurses in the Heart Failure Hospitalizations of African American Patients: Cross-Sectional Study
- An instrument for measuring the influence of nursing care on the length of stay in heart failure hospitalizations of African Americans
- Falls Risk Associated With Referral Diagnosis for Older Adults Receiving Outpatient Physical Therapy Services
Fen Xia
University of Arkansas for Medical Sciences
4 shared publications
In database
- #Brachytherapy: Physicians As Influencers on Instagram
- The effect of anticonvulsants on survival among patients with GBM brain tumors undergoing radiation: A SEER-Medicare analysis
- A dosimetric comparative analysis of Brainlab elements and Eclipse RapidArc for spine SBRT treatment planning
- Producing high quality cranial SRS plans with 4Pi planning technique in a commercial clinical solution
Jasmine Crane
University of Arkansas for Medical Sciences
4 shared publications
In database
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- Immune responses in a phase 2 clinical trial of peptide-based therapeutic human papillomavirus vaccine, PepCan, versus Candida adjuvant alone in treating cervical intraepithelial neoplasia 2/3.
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
- A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence
Nadia Darwish
University of Arkansas for Medical Sciences
4 shared publications
In database
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- Immune responses in a phase 2 clinical trial of peptide-based therapeutic human papillomavirus vaccine, PepCan, versus Candida adjuvant alone in treating cervical intraepithelial neoplasia 2/3.
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
- A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence
Intawat Nookaew
University of Arkansas for Medical Sciences
4 shared publications
In database
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- Immune responses in a phase 2 clinical trial of peptide-based therapeutic human papillomavirus vaccine, PepCan, versus Candida adjuvant alone in treating cervical intraepithelial neoplasia 2/3.
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
- A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence
Keanna Marsh
University of Arkansas for Medical Sciences
4 shared publications
In database
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- Immune responses in a phase 2 clinical trial of peptide-based therapeutic human papillomavirus vaccine, PepCan, versus Candida adjuvant alone in treating cervical intraepithelial neoplasia 2/3.
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
- A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence
Maryam Y. Garza
The University of Texas at San Antonio Health Science Center (US)
4 shared publications
- Social determinants of health and hospitalization risk in heart failure: A Retrospective analysis
- Registered nurse effect on long length of stay in the heart failure hospitalizations of African Americans
- Sociotechnical Needs of Registered Nurses in the Heart Failure Hospitalizations of African American Patients: Cross-Sectional Study
- An instrument for measuring the influence of nursing care on the length of stay in heart failure hospitalizations of African Americans
Alisha Crump
University of Arkansas for Medical Sciences
4 shared publications
In database
- Social determinants of health and hospitalization risk in heart failure: A Retrospective analysis
- Registered nurse effect on long length of stay in the heart failure hospitalizations of African Americans
- Sociotechnical Needs of Registered Nurses in the Heart Failure Hospitalizations of African American Patients: Cross-Sectional Study
- An instrument for measuring the influence of nursing care on the length of stay in heart failure hospitalizations of African Americans
Taren Swindle
University of Arkansas for Medical Sciences
4 shared publications
In database
- Social determinants of health and hospitalization risk in heart failure: A Retrospective analysis
- Registered nurse effect on long length of stay in the heart failure hospitalizations of African Americans
- Sociotechnical Needs of Registered Nurses in the Heart Failure Hospitalizations of African American Patients: Cross-Sectional Study
- An instrument for measuring the influence of nursing care on the length of stay in heart failure hospitalizations of African Americans
Frits van Rhee
Winthrop Rockefeller Foundation
3 shared publications
In database
- EARLY Results of TOTAL Therapy 7 (TT7): High Response Rates of NEWLY Diagnosed High Risk Myeloma to Daratumumab
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
- Predicting Risk of Progression in Relapsed Multiple Myeloma Using Minimal Residual Disease Status and Focal Lesion Assessment with PET-CT
Sharmilan Thanendrarajan
Winthrop Rockefeller Foundation
3 shared publications
In database
- EARLY Results of TOTAL Therapy 7 (TT7): High Response Rates of NEWLY Diagnosed High Risk Myeloma to Daratumumab
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
- Predicting Risk of Progression in Relapsed Multiple Myeloma Using Minimal Residual Disease Status and Focal Lesion Assessment with PET-CT
Carolina Schinke
Winthrop Rockefeller Foundation
3 shared publications
In database
- EARLY Results of TOTAL Therapy 7 (TT7): High Response Rates of NEWLY Diagnosed High Risk Myeloma to Daratumumab
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
- Predicting Risk of Progression in Relapsed Multiple Myeloma Using Minimal Residual Disease Status and Focal Lesion Assessment with PET-CT
Maurizio Zangari
Winthrop Rockefeller Foundation
3 shared publications
In database
- EARLY Results of TOTAL Therapy 7 (TT7): High Response Rates of NEWLY Diagnosed High Risk Myeloma to Daratumumab
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
- Predicting Risk of Progression in Relapsed Multiple Myeloma Using Minimal Residual Disease Status and Focal Lesion Assessment with PET-CT
P Rubinstein
John H. Stroger, Jr. Hospital of Cook County (US)
3 shared publications
- Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
- Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085
- Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study
Page C. Moore
University of Arkansas for Medical Sciences (US)
3 shared publications
- Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
- Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085
- Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study
Similar Researchers
Based on overlapping research topics
S. Hoey
University of Arkansas for Medical Sciences
Medical Research
Retrospective Studies
Public Health Research
A. Stevens
University of Arkansas for Medical Sciences
Medical Research
Retrospective Studies
Organ Transplantation Techniques and Outcomes
G. Barone
University of Arkansas for Medical Sciences
Medical Research
Retrospective Studies
Organ Transplantation Techniques and Outcomes
Sawan Attwal
University of Arkansas for Medical Sciences
Retrospective Studies
Public Health Research
Diet and Metabolism Studies
Sanjay Maraboyina
University of Arkansas for Medical Sciences
Medical Research
Retrospective Studies
Cancer Treatment and Pharmacology
Emmaouil Giorgakis
University of Arkansas for Medical Sciences
Retrospective Studies
Public Health Research
Cancer Treatment and Pharmacology